Synapse Open Synapse
Biology

Alzheimer’s Small-Molecule Therapy Shows Promise in Mice and Early Human Trial

GEN · · 2 min read

A small-molecule therapy, VG-3927, targeting microglial TREM2 signaling showed neuroprotective effects in preclinical studies for Alzheimer's disease and was well tolerated in a Phase I trial.

Latest from GEN